STERIS plc (NYSE:STE)
| 203.49 Delayed Data As of Dec 01 |  +2.55 / +1.27%Today’s Change | 173.21 Today|||52-Week Range 254.00 | +10.18% Year-to-Date |
Latest STE News | Press Releases
| Here's Why Investors Should Retain STERIS (STE) Stock for Now Nov 21 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 200.94 |
| Today’s open | 199.29 |
| Day’s range | 199.24 - 204.45 |
| Volume | 363,204 |
| Average volume (3 months) | 389,754 |
| Market cap | $20.1B |
Data as of 4:00pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -57.07% |
| Earnings growth (this year) | +5.80% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +8.13% |
| P/E ratio | 36.9 |
| Price/Sales | 3.87 |
| Price/Book | 3.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNNSmith & Nephew PLC | +0.43 | +1.66% |
| ---- | ||
| MSAMSA Safety Inc | +2.38 | +1.37% |
| GMEDGlobus Medical Inc | +1.09 | +2.43% |
Data as of 4:00pm ET, 12/01/2023
Financials
| Next reporting date | February 8, 2024 |
| EPS forecast (this quarter) | $2.24 |
| Annual revenue (last year) | $5.0B |
| Annual profit (last year) | $107.0M |
| Net profit margin | 2.16% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
